Evaluation of upper abdominal symptoms using the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease in patients with laryngopharyngeal reflux symptoms

Takeda, Hiroshi; Mesuda, Yasushi; Nishizawa, Noriko; Furuta, Yasushi; Asaka, Masahiro; Fukuda, Satoshi

doi:10.1007/s00535-008-2189-2

Cited by 13 publications

(13 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We used the FSSG to assess GERD-like symptoms at a cutoff score of 8 points [16,18]. Among the 12 question of the FSSG, seven items are related to reflux symptoms (FSSG-RS).…”

Section: Measured Outcomesmentioning

confidence: 99%

Proton pump inhibitor after endoscopic resection for esophageal squamous cell cancer: multicenter prospective randomized controlled trial

et al. 2015

View full text Add to dashboard Cite

show abstract

“…We used the FSSG to assess GERD-like symptoms at a cutoff score of 8 points [16,18]. Among the 12 question of the FSSG, seven items are related to reflux symptoms (FSSG-RS).…”

Section: Measured Outcomesmentioning

confidence: 99%

Proton pump inhibitor after endoscopic resection for esophageal squamous cell cancer: multicenter prospective randomized controlled trial

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Also, LPR symptoms improve more slowly than esophageal symptoms after acid suppression therapy and 4 weeks of acid suppression therapy may not be long enough to fully estimate the effects of PPI therapy [15,16]. In our study, after 4 weeks of PPI treatment, both FSSG scores and LPR symptom scores were decreased, but the differences between pre-treatment and post-treatment values were not correlated.…”

Section: Discussionmentioning

confidence: 56%

“…In our study, after 4 weeks of PPI treatment, both FSSG scores and LPR symptom scores were decreased, but the differences between pre-treatment and post-treatment values were not correlated. Oridate et al [15] evaluated upper abdominal symptoms using FSSG in patients with LPR symptoms and they found a poor correlation between a positive rate for upper abdominal symptoms on FSSG and the frequency of LPR symptoms.…”

Section: Discussionmentioning

confidence: 98%

Comparative outcomes of antireflux treatment for laryngopharyngeal reflux symptoms and upper abdominal symptoms in patients with endoscopic esophagitis

Toros¹,

Toros

Özel

et al. 2010

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

The objectives of this prospective study are to determine the prevalence of laryngopharyngeal reflux (LPR) symptoms in patients with endoscopic esophagitis, to investigate the relationship between LPR symptoms and upper abdominal symptoms of gastroesophageal reflux disease (GERD) and to compare the treatment responses of both symptom groups. 120 consecutive patients having complaints of GERD were included. Group I consisted of 62 patients with a diagnosis of endoscopic esophagitis. The second group consisted of 58 subjects with no detectable pathology at gastroscopy. LPR symptoms and upper abdominal symptoms were graded. Proton pump inhibitors (PPI) were prescribed to patients. Both groups of symptoms were compared in two groups of patients. The improvement in symptoms was evaluated after treatment. The frequencies of LPR symptoms were statistically higher in patients with endoscopic esophagitis. All LPR symptoms were statistically relieved in their frequency after treatment. The decrease in LPR symptom scores after treatment in group I was statistically significant. FSSG (frequency scale for the symptoms of GERD) scores were statistically higher in group I than in group II before treatment. After treatment, FSSG scores were significantly decreased in group I. There was statistically significant positive correlation between the LPR symptom scores and FSSG scores before treatment. In conclusion, there is a high incidence of LPR symptoms and upper abdominal symptoms in patients with endoscopic esophagitis. LPR and upper abdominal symptoms responded well to antireflux treatment in patients with endoscopic esophagitis.

show abstract

“…They reported that it showed a sensitivity of 62%, specificity of 59%, and accuracy of 60% when the c score was set at 8 points and F utoff SSG is widely used to evaluate GERD symptoms thereafter [13][14][15]. In this study, mean score of FSSG before starting the program was 8.6 and 30% of patients was equal or more than 8 points.…”

Section: Discussionmentioning

confidence: 73%

Quit smoking improves gastroesophageal reflux symptoms and quality of life

Nakajima¹,

Nagahara²,

Kurosawa³

et al. 2011

Health

View full text Add to dashboard Cite

Background: Smoking is considered to be risk factors of gastroesophageal reflux disease (GERD). The present study aimed to reveal whether quit smoking improves GERD symptoms and QOL of patients. Methods: In this prospective study, 33 patients who participated in a 12-week quit smoking program filled out the Frequency Scale for the Symptoms of GERD (FSSG) questionnaire, and SF8 QOL questionnaire. Patients filled out the questionnaires at baseline and during the program at 2 weeks, 4 weeks, 8 weeks and 12 weeks. In the FSSG, the responses were scored and the reflux score (RS), dysmotility score (DS) and total score (TS) were calculated. Results: There were 22 males and 11 females. Their mean age was 54.8 ± 13.0 (mean ± SD) yr, BMI was 22.9 ± 4.0, and duration of smoking was 33.5 ± 12.5 years. Ten patients belonged to GERD subgroup (baselineFSSGscore ≥ 8). All patients were successful at quit smoking. Scores of TS/RS/DS are 8.6 ± 1.8 (mean ± SE)/4.2 ± 0.9/4.5 ± 0.9 at baseline, 4

show abstract

Evaluation of upper abdominal symptoms using the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease in patients with laryngopharyngeal reflux symptoms

Cited by 13 publications

References 17 publications

Proton pump inhibitor after endoscopic resection for esophageal squamous cell cancer: multicenter prospective randomized controlled trial

Proton pump inhibitor after endoscopic resection for esophageal squamous cell cancer: multicenter prospective randomized controlled trial

Comparative outcomes of antireflux treatment for laryngopharyngeal reflux symptoms and upper abdominal symptoms in patients with endoscopic esophagitis

Quit smoking improves gastroesophageal reflux symptoms and quality of life

Contact Info

Product

Resources

About